Target Name: VAMP5
NCBI ID: G10791
Review Report on VAMP5 Target / Biomarker Content of Review Report on VAMP5 Target / Biomarker
VAMP5
Other Name(s): Myobrevin | Vesicle associated membrane protein 5 | Vesicle-associated membrane protein 5 | VAMP-5 | VAMP5_HUMAN | vesicle associated membrane protein 5 | myobrevin

VAMP5: A Protein Regulator of Muscle Growth and Maintenance

VAMP5 (Myobrevin) is a protein that is expressed in muscle tissue and is known for its role in muscle growth and maintenance. It is a key regulator of muscle protein synthesis and has been shown to play a crucial role in muscle development and maintenance.

Recent studies have identified VAMP5 as a potential drug target for muscle-related conditions, including muscle dystrophy, muscle weakness, and muscle wasting. The exact mechanism by which VAMP5 promotes muscle growth and maintenance is not yet fully understood, but it is thought to involved in the regulation of several key processes that are involved in muscle development and function.

One of the key functions of VAMP5 is its role in the regulation of protein synthesis. Protein synthesis is the process by which the body builds and repairs its proteins, and VAMP5 is known to be involved in the production of muscle protein. Studies have shown that VAMP5 plays a critical role in the regulation of muscle protein synthesis and that defects in VAMP5 have been linked to muscle protein synthesis disorders.

Another function of VAMP5 is its role in the regulation of muscle cell growth and maintenance. muscle cells are constantly dividing and growing, and VAMP5 is known to be involved in the regulation of cell growth and differentiation. studies have shown that VAMP5 plays a critical role in the regulation of muscle cell growth and that defects in VAMP5 have been linked to muscle cell dysfunction and failure.

In addition to its role in protein synthesis and cell growth, VAMP5 is also thought to be involved in the regulation of muscle inflammation. muscle inflammation is a common complication in muscle-related conditions, and VAMP5 is known to be involved in the regulation of inflammation response. studies have shown that VAMP5 plays a critical role in the regulation of muscle inflammation and that defects in VAMP5 have been linked to increased muscle inflammation.

VAMP5 is also a potential biomarker for muscle-related conditions, such as muscle dystrophy, muscle weakness, and muscle wasting. The exact mechanisms by which VAMP5 is involved in these conditions is not yet fully understood, but studies have shown that VAMP5 is involved in the regulation of several key processes that are involved in muscle health and function.

In conclusion, VAMP5 is a protein that is expressed in muscle tissue and is known for its role in muscle growth and maintenance. Recent studies have identified VAMP5 as a potential drug target for muscle-related conditions, including muscle dystrophy, muscle weakness, and muscle wasting. The exact mechanism by which VAMP5 promotes muscle growth and maintenance is not yet fully understood, but it is thought to involve the regulation of several key processes that are involved in muscle development and function. Further research is needed to fully understand the role of VAMP5 in muscle health and to develop effective treatments for muscle-related conditions.

Protein Name: Vesicle Associated Membrane Protein 5

Functions: May participate in trafficking events that are associated with myogenesis, such as myoblast fusion and/or GLUT4 trafficking

The "VAMP5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about VAMP5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

VAMP7 | VAMP8 | VANGL1 | VANGL2 | VAPA | VAPB | VARS1 | VARS2 | Vascular endothelial growth factor receptor (VEGFR) | Vascular endothelial growth factors (VEGF) | VASH1 | VASH1-AS1 | VASH2 | VASN | Vasoactive intestinal polypeptide receptor (VIP-R) | Vasohibin | Vasopressin Receptor | Vasopressin V1 Receptor | VASP | VAT1 | VAT1L | VAV1 | VAV2 | VAV3 | VAV3-AS1 | VAX1 | VAX2 | VBP1 | VCAM1 | VCAN | VCL | VCP | VCPIP1 | VCPKMT | VCX | VCX2 | VCX3A | VCX3B | VCY | VCY1B | VDAC1 | VDAC1P2 | VDAC1P9 | VDAC2 | VDAC2P5 | VDAC3 | VDR | VEGFA | VEGFB | VEGFC | VEGFD | VENTX | VENTXP1 | VENTXP7 | VEPH1 | VEZF1 | VEZT | VGF | VGLL1 | VGLL2 | VGLL3 | VGLL4 | VHL | VIL1 | VILL | VIM | VIP | VIPAS39 | VIPR1 | VIPR1-AS1 | VIPR2 | VIRMA | VIT | VKORC1 | VKORC1L1 | VLDLR | VLDLR-AS1 | VMA21 | VMAC | VMO1 | VMP1 | VN1R1 | VN1R101P | VN1R108P | VN1R10P | VN1R11P | VN1R12P | VN1R17P | VN1R18P | VN1R2 | VN1R4 | VN1R46P | VN1R5 | VN1R82P | VN1R91P | VN1R96P | VN2R11P | VN2R1P | VN2R3P | VNN1